@article {LEE2407, author = {YEN-JU LEE and JING-GUNG CHUNG and ZHAO-LIN TAN and FEI-TING HSU and YU-CHANG LIU and SONG-SHEI LIN}, title = {ERK/AKT Inactivation and Apoptosis Induction Associate With Quetiapine-inhibited Cell Survival and Invasion in Hepatocellular Carcinoma Cells}, volume = {34}, number = {5}, pages = {2407--2417}, year = {2020}, doi = {10.21873/invivo.12054}, publisher = {International Institute of Anticancer Research}, abstract = {Background/Aim: Quetiapine, an atypical antipsychotic, has been encountered as a potential protective agent to suppress various types of tumor growth. However, the inhibitory mechanism of quetiapine in hepatocellular carcinoma (HCC) still remains unclear. The purpose of present study was to investigate the inhibitory mechanism of quetiapine on cell survival and invasion in HCC. Materials and Methods: Changes of apoptotic signaling, migration/invasion ability, and signaling transduction involved in cell survival and invasion were evaluated with flow cytometry, migration/invasion, and western blot assays. Results: Quetiapine inhibited cell proliferation and migration/invasion in SK-Hep1 and Hep3B cells. Quetiapine induced extrinsic and intrinsic apoptotic pathways. Activation of extracellular signal-regulated kinases (ERK), protein kinase B (AKT), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB), expression of anti-apoptotic, and metastasis-associated proteins were decreased by quetiapine. Conclusion: The apoptosis induction, the decreased expression of ERK/AKT-mediated anti-apoptotic and the metastasis-associated proteins were associated with quetiapine-inhibited cell survival and invasion in HCC in vitro.}, issn = {0258-851X}, URL = {https://iv.iiarjournals.org/content/34/5/2407}, eprint = {https://iv.iiarjournals.org/content/34/5/2407.full.pdf}, journal = {In Vivo} }